S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
Stock market today: Wall Street drifts to a mixed finish as yields tick higher
How major US stock indexes fared Thursday, 4/18/2024
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$1.14
+2.7%
$1.22
$0.84
$2.03
$43.47M0.99122,139 shs89,437 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$20.86
C$18.60
C$22.79
N/AN/A468,009 shs3.04 million shs
Guess?, Inc. stock logo
GES
Guess?
$25.56
+0.2%
$26.88
$17.21
$33.50
$1.36B1.981.19 million shs935,754 shs
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-3.48%-11.20%-2.63%-9.02%-26.49%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
First Capital Realty Inc. stock logo
FCR
First Capital Realty
0.00%0.00%0.00%0.00%0.00%
Guess?, Inc. stock logo
GES
Guess?
+0.95%-10.70%+2.04%+14.22%+30.04%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
1.5505 of 5 stars
3.50.00.00.00.63.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/AN/AN/A
Guess?, Inc. stock logo
GES
Guess?
4.0648 of 5 stars
3.11.03.30.02.94.22.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3.00
Buy$7.00514.04% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/A
Guess?, Inc. stock logo
GES
Guess?
2.25
Hold$32.0025.20% Upside

Current Analyst Ratings

Latest GES, BOLT, CZX, and FCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/8/2024
Guess?, Inc. stock logo
GES
Guess?
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$33.00 ➝ $37.00
3/25/2024
Guess?, Inc. stock logo
GES
Guess?
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$26.00 ➝ $32.00
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
3/21/2024
Guess?, Inc. stock logo
GES
Guess?
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$24.00 ➝ $29.00
3/21/2024
Guess?, Inc. stock logo
GES
Guess?
Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$23.00 ➝ $30.00
3/15/2024
Guess?, Inc. stock logo
GES
Guess?
Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform$23.00 ➝ $30.00
2/21/2024
Guess?, Inc. stock logo
GES
Guess?
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$31.00 ➝ $33.00
2/20/2024
Guess?, Inc. stock logo
GES
Guess?
Telsey Advisory Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform ➝ Market Perform$23.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M5.52N/AN/A$2.97 per share0.38
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/A
Guess?, Inc. stock logo
GES
Guess?
$2.78B0.49$4.48 per share5.71$13.68 per share1.87

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.83N/AN/AN/A-878.58%-51.18%-37.81%5/9/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/A0.00N/AN/AN/AN/AN/A5/1/2024 (Confirmed)
Guess?, Inc. stock logo
GES
Guess?
$198.20M$2.908.818.06N/A7.14%30.02%6.96%5/22/2024 (Estimated)

Latest GES, BOLT, CZX, and FCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.29N/A-C$0.29N/AN/AN/A
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million
3/20/2024Q4 23
Guess?, Inc. stock logo
GES
Guess?
$1.55$2.01+$0.46$2.31$855.54 million$891.05 million    
2/6/2024Q4 2023
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.31C$0.81+C$0.50C$0.81N/AC$171.18 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/A
Guess?, Inc. stock logo
GES
Guess?
$1.204.69%+71.00%41.38%2 Years

Latest GES, BOLT, CZX, and FCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.074.14%4/29/20244/30/20245/15/2024
3/20/2024
Guess?, Inc. stock logo
GES
Guess?
quarterly$0.304.62%4/16/20244/17/20245/3/2024
3/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.073/27/20243/28/20244/15/2024
2/6/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.072/28/20242/29/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.15
5.17
5.17
CZX
Canada Zinc Metals
N/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/A
Guess?, Inc. stock logo
GES
Guess?
0.50
1.55
0.96

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Guess?, Inc. stock logo
GES
Guess?
61.74%

Insider Ownership

CompanyInsider Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
28.40%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
Guess?, Inc. stock logo
GES
Guess?
49.10%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million27.30 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/ANot Optionable
Guess?, Inc. stock logo
GES
Guess?
12,00053.18 million27.07 millionOptionable

GES, BOLT, CZX, and FCR Headlines

SourceHeadline
Guess? (GES) Benefits From Brand Momentum Amid Macro HeadwindsGuess? (GES) Benefits From Brand Momentum Amid Macro Headwinds
zacks.com - April 18 at 11:00 AM
Guess?, Inc. (NYSE:GES) Short Interest Up 6.3% in MarchGuess?, Inc. (NYSE:GES) Short Interest Up 6.3% in March
americanbankingnews.com - April 18 at 2:22 AM
Guess?, Inc. (NYSE:GES) Given Consensus Recommendation of "Hold" by AnalystsGuess?, Inc. (NYSE:GES) Given Consensus Recommendation of "Hold" by Analysts
americanbankingnews.com - April 17 at 2:34 AM
Guess? (NYSE:GES) Sees Unusually-High Trading VolumeGuess? (NYSE:GES) Sees Unusually-High Trading Volume
marketbeat.com - April 16 at 2:58 PM
Guess?, Inc. (NYSE:GES) Short Interest UpdateGuess?, Inc. (NYSE:GES) Short Interest Update
marketbeat.com - April 16 at 12:23 PM
Guess? Incs Dividend AnalysisGuess? Inc's Dividend Analysis
finance.yahoo.com - April 15 at 8:11 AM
Guess (GES) Stock Drops Despite Market Gains: Important Facts to NoteGuess (GES) Stock Drops Despite Market Gains: Important Facts to Note
zacks.com - April 11 at 7:21 PM
Should You Think About Buying Guess?, Inc. (NYSE:GES) Now?Should You Think About Buying Guess?, Inc. (NYSE:GES) Now?
finance.yahoo.com - April 11 at 8:40 AM
Q1 2025 EPS Estimates for Guess?, Inc. Cut by B. Riley (NYSE:GES)Q1 2025 EPS Estimates for Guess?, Inc. Cut by B. Riley (NYSE:GES)
americanbankingnews.com - April 11 at 1:36 AM
B. Riley Comments on Guess?, Inc.s Q1 2025 Earnings (NYSE:GES)B. Riley Comments on Guess?, Inc.'s Q1 2025 Earnings (NYSE:GES)
marketbeat.com - April 10 at 8:28 AM
Can Guess? Fuel an Abercrombie-Like Short Squeeze? Can Guess? Fuel an Abercrombie-Like Short Squeeze?
marketbeat.com - April 10 at 8:00 AM
Guess?, Inc. (NYSE:GES) CEO Carlos Alberini Sells 211,797 Shares of StockGuess?, Inc. (NYSE:GES) CEO Carlos Alberini Sells 211,797 Shares of Stock
americanbankingnews.com - April 10 at 4:54 AM
Guess?, Inc. (NYSE:GES) CEO Carlos Alberini Sells 138,203 Shares of StockGuess?, Inc. (NYSE:GES) CEO Carlos Alberini Sells 138,203 Shares of Stock
americanbankingnews.com - April 10 at 4:54 AM
Insider Selling: Guess?, Inc. (NYSE:GES) CEO Sells 138,203 Shares of StockInsider Selling: Guess?, Inc. (NYSE:GES) CEO Sells 138,203 Shares of Stock
insidertrades.com - April 10 at 4:53 AM
Insider Selling: Guess?, Inc. (NYSE:GES) CEO Sells 211,797 Shares of StockInsider Selling: Guess?, Inc. (NYSE:GES) CEO Sells 211,797 Shares of Stock
insidertrades.com - April 10 at 4:53 AM
Guess? (NYSE:GES) Given Buy Rating at B. RileyGuess? (NYSE:GES) Given Buy Rating at B. Riley
americanbankingnews.com - April 9 at 4:22 AM
Guess? (GES) Benefits From Brand Strength & Key StrategiesGuess? (GES) Benefits From Brand Strength & Key Strategies
zacks.com - April 8 at 10:35 AM
B. Riley Reiterates Buy Rating for Guess? (NYSE:GES)B. Riley Reiterates Buy Rating for Guess? (NYSE:GES)
marketbeat.com - April 8 at 10:29 AM
Venture Visionary Partners LLC Invests $1.07 Million in Guess?, Inc. (NYSE:GES)Venture Visionary Partners LLC Invests $1.07 Million in Guess?, Inc. (NYSE:GES)
marketbeat.com - April 7 at 7:44 AM
GMFS More or Less What’s Your Guess?GMFS More or Less What’s Your Guess?
msn.com - April 5 at 2:36 AM
Guess?, Inc. and WHP Global Complete Acquisition of rag & boneGuess?, Inc. and WHP Global Complete Acquisition of rag & bone
latimes.com - April 4 at 4:34 PM
Guess?s (GES) Latest Acquisition Move to Diversify PortfolioGuess?'s (GES) Latest Acquisition Move to Diversify Portfolio
zacks.com - April 4 at 2:21 PM
Guess? And WHP Global Closes Acquisition Of Rag & BoneGuess? And WHP Global Closes Acquisition Of Rag & Bone
markets.businessinsider.com - April 3 at 8:57 AM
Guess?, Inc. and WHP Global Complete the Acquisition of rag & bone
Guess?, Inc. Announces $50 Million Expansion of its Existing Asset-Based Revolving Credit FacilityGuess?, Inc. and WHP Global Complete the Acquisition of rag & bone Guess?, Inc. Announces $50 Million Expansion of its Existing Asset-Based Revolving Credit Facility
finance.yahoo.com - April 3 at 8:57 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
First Capital Realty logo

First Capital Realty

TSE:FCR
Guess? logo

Guess?

NYSE:GES
Guess?, Inc. designs, markets, distributes, and licenses lifestyle collections of apparel and accessories for men, women, and children. It operates through five segments: Americas Retail, Americas Wholesale, Europe, Asia, and Licensing. The company's clothing collection includes jeans, pants, skirts, dresses, shorts, blouses, shirts, jackets, activewear, knitwear, and intimate apparel. It also grants licenses to design, manufacture, and distribute various products that complement its apparel lines, such as eyewear, watches, handbags, footwear, kids' and infants' apparel, outerwear, fragrance, jewelry, and other fashion accessories, as well as to wholesale partners to operate and sell products through licensed retail stores. The company markets its products under the GUESS, GUESS?, GUESS U.S.A., GUESS Jeans, GUESS? and Triangle Design, MARCIANO, Question Mark and Triangle Design, a stylized G and a stylized M, GUESS Kids, Baby GUESS, YES, G by GUESS, GUESS by MARCIANO, and Gc brand names. It sells its products through direct-to-consumer, wholesale, and licensing distribution channels, as well as through its retail websites. Guess?, Inc. was founded in 1981 and is headquartered in Los Angeles, California.